Aspiro Pharma Limited - Company Profile

It is a pharma public limited company based in Markook, Telangana, India, established in 2014.
2014 Markook, Telangana, India Active
Last Updated:
Access Report
About Aspiro Pharma Limited

Aspiro Pharma Limited, a active public limited company, was established on 05 February 2014 in Markook, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100TG2014PLC092771. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1,470.10 Cr and a paid-up capital of ₹1,004.15 Cr.

It upholds a compliant status. Employing 408 professional, Its leadership includes Bandi Vamsikrishna (Director), Reddy Narsimha (Director), Krishnaveni Kura (Director). Past directors included Gopala Krishna Rampalli, Venkateswarreddy Sandadi, Buchiram Venkat Sobhanadri Suri. It holds ₹206.91 Cr open charges and ₹46.89 Cr settled loans. Its latest AGM occurred on 24 July 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. 23, Survey No.321, Biotech Park Phase-Iii, Karkapatla Villa, Ge,, Markook, Telangana, 502281.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100TG2014PLC092771

  • Registration Number

    092771

  • Incorporation Date

    05 February 2014

  • Authorized Capital

    ₹1,470.10 Cr

  • Paid-Up Capital

    ₹1,004.15 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1,470.10 Cr
  • Paid Up Capital ₹ 1,004.15 Cr
  • Company Age 12 Year, 25 Days
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 206.91 Cr
  • Satisfied Charges ₹ 46.89 Cr
  • Revenue Growth **** 16.47%
  • Profit Growth **** -69.63%
  • Ebitda **** -178.47%
  • Net Worth -21.68%
  • Total Assets **** 28.66%
Company report

Aspiro Pharma Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Aspiro Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Aspiro Pharma Limited?
Current Directors
Name Designation Appointment Date Status
Bandi Vamsikrishna Director 13 Feb 2014 Current
Reddy Narsimha Director 03 Aug 2024 Current
Krishnaveni Kura Director 29 Jun 2017 Current
Ramaseshappa Siva Prasad Panchangam Director 03 Aug 2023 Current
Mahesh Ramappa Kamalamma Hassan Director 07 Jun 2023 Current
Bhaskarreddy Pabbatireddy Additional Director 10 Oct 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 17 Aug 2017 Past
Pramod Abcsdd Director 13 Feb 2014 Past
Pramod Abcsdd Additional Director 17 Aug 2017 Past
Pramod Abcsdd Additional Director 25 Sep 2014 Past
Pramod Abcsdd Director 13 Feb 2014 Past
Pramod Abcsdd Additional Director 18 Aug 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aspiro Pharma.

Aspiro Pharma Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.47% increase. The company also saw a substantial fall in profitability, with a 69.63% decrease in profit. The company's net worth observed a substantial decline by a decrease of 21.68%.

Aspiro Pharma revenue growth over time
Aspiro Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 16.47%
*******
*******
*******
*******
Revenue from Operations
*******
 14.56%
*******
*******
*******
*******
Total Assets
*******
 28.66%
*******
*******
*******
*******
Profit or Loss
*******
 -69.63%
*******
*******
*******
*******
Net Worth
*******
 -21.68%
*******
*******
*******
*******
EBITDA
*******
 -178.47%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aspiro Pharma?

In 2023, Aspiro Pharma had a promoter holding of 99.83% and a public holding of 0.17%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹2,069,111,003.00

Satisfied Charges

₹468,900,000.00

Charges Breakdown by Lending Institutions
  • Others : 206.24 Cr
  • Hdfc Bank Limited : 0.67 Cr
Latest Charge Details
Date Lender Amount Status
30 Sep 2024 Others ₹100.00 Cr Open
10 May 2024 Others ₹0.90 M Open
03 Apr 2024 Others ₹105.00 Cr Open
04 Nov 2023 Others ₹1.30 M Open
26 Oct 2023 Others ₹1.02 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Aspiro Pharma?

Aspiro Pharma has a workforce of 408 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aspiro Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aspiro Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aspiro Pharma
Recent Activity within the Organization
  • Director Appointment

    The activity Bhaskarreddy Pabbatireddy was appointed as a Additional Director was appointed as a Additional Director on 10 Oct 2025 & has been associated with this company since 4 months 23 days . was completed.

  • Annual General Meeting

    The activity Aspiro Pharma Limited last Annual general meeting of members was held on 24 Jul 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Aspiro Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was recorded as a recent event.

  • Charges

    The activity A charge registered on 29 Apr 2015 via Charge ID 10569865 with State Bank Of Mysore was fully satisfied on 18 Nov 2024. was completed.

  • Charges

    A charge with Others amounted to Rs. 100.00 Cr with Charge ID 100989753 was registered on 30 Sep 2024. was recorded as a recent event.

  • Director Appointment

    The activity Reddy Narsimha was appointed as a Director was appointed as a Director on 03 Aug 2024 & has been associated with this company since 1 year 6 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Aspiro Pharma Limited?

The CIN of Aspiro Pharma Limited is U24100TG2014PLC092771.

Where is Aspiro Pharma Limited headquartered?

Aspiro Pharma Limited is headquartered at Plot No. 23, Survey No.321, Biotech Park Phase-Iii, Karkapatla Villa, Ge,, Markook, Telangana, 502281.

When was Aspiro Pharma Limited incorporated?

Aspiro Pharma Limited was incorporated on 05 February 2014.

Who are the current directors of Aspiro Pharma Limited?

The current directors of Aspiro Pharma Limited are

What is the primary industry of Aspiro Pharma Limited?

The primary industry of Aspiro Pharma Limited is Manufacturing.

Is Aspiro Pharma Limited a listed company?

Aspiro Pharma Limited is unlisted.

What is the capital structure of Aspiro Pharma Limited?

The authorized capital of Aspiro Pharma Limited is ₹1,470.10 Cr, and the paid-up capital is ₹1,004.15 Cr.

What is the compliance status of Aspiro Pharma Limited?

The compliance status of Aspiro Pharma Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available